Although a role for the CaSR in medulloblastoma has not been established, the identification of key proteins regulating GCP migration and progression is a major goal in medulloblastoma research, and could lead to novel approaches for the development of effective therapeutics. This evidence concerns the gene CASR and medulloblastoma.